IndraLab

Statements


USP25 deubiquitinates FOXM1. 10 / 10
| 10

reach
"Subsequently, Arceci et al. revealed that USP21 amplification was related to proliferation and paclitaxel resistance in basal-like breast cancer (BLBC) by deubiquitylating and stabilizing the cell cycle transcription factor FoxM1 (Arceci et al., 2019)."

reach
"Likewise, FoxM1 deubiquitylation by USP21 contributes to both cell growth and radioresistance in cervical cancer (Li et al., 2022)."

reach
"FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal like Breast Cancer."

reach
"USP21 increases the stability of FOXM1, and USP21 binds and deubiquitinates FOXM1 in vivo and in vitro, indicating a direct enzyme-substrate relationship."

reach
"Similarly, USP21 WT, but not USP21 C221A, immunopurified from 293T cells reduced polyubiquitination of FOXM1 isolated from proteasome inhibitor treated 293T cells in an in vitro deubiquitination assay (XREF_SUPPLEMENTARY)."

reach
"In addition, USP21 deubiquitinates FOXM1 to strengthen radioresistance in cervical cancer through the Hippo signaling pathway[17]."

reach
"Another study about basal-like breast cancer reported that USP21 promoted the progression of the cell cycle and resistance to paclitaxel by regulating FOXM1 deubiquitination [15]."

reach
"HDACi treatment increased the ubiquitination level of FOXM1 by suppressing ubiquitin-specific peptidase 21 (USP21), which deubiquitinates FOXM1."

reach
"USP21 binds and deubiquitinates FOXM1 in vivo and in vitro, thus increasing FOXM1 stability."

reach
"FOXM1 deubiquitinated by USP21 modulates cell cycle and paclitaxel sensitivity of basal-like breast cancer cells [38]."